loadpatents
name:-0.057746887207031
name:-0.032565116882324
name:-0.0063049793243408
Loibner; Hans Patent Filings

Loibner; Hans

Patent Applications and Registrations

Patent applications and USPTO patent grants for Loibner; Hans.The latest application filed is for "preparations and methods for treating a gd2 positive cancer".

Company Profile
6.38.58
  • Loibner; Hans - Vienna AT
  • LOIBNER; Hans - Wien AT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for treating a GD2 positive cancer
Grant 11,447,565 - Loibner , et al. September 20, 2
2022-09-20
Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
Grant 11,079,398 - Poglitsch , et al. August 3, 2
2021-08-03
Preparations And Methods For Treating A Gd2 Positive Cancer
App 20210221909 - LOIBNER; Hans ;   et al.
2021-07-22
Preparations and methods for treating a GD2 positive cancer
Grant 10,995,147 - Loibner , et al. May 4, 2
2021-05-04
Preparations And Methods For Treating A Gd2 Positive Cancer
App 20200332021 - LOIBNER; Hans ;   et al.
2020-10-22
Method for producing ACE2 polypeptide
Grant 10,716,833 - Schuster , et al.
2020-07-21
Method for Treating a GD2 Positive Cancer
App 20200055953 - Loibner; Hans ;   et al.
2020-02-20
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases
Grant 10,472,341 - Ermann , et al. Nov
2019-11-12
Method for treating a GD2 positive cancer
Grant 10,294,305 - Loibner , et al.
2019-05-21
Method Of Treating Lung, Kidney, Or Heart Disease With A Recombinant Ace2 Polypeptide Dimer
App 20180289779 - Schuster; Manfred ;   et al.
2018-10-11
Preparations And Methods For Treating A Gd2 Positive Cancer
App 20180258183 - LOIBNER; Hans ;   et al.
2018-09-13
Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System
App 20180200330 - POGLITSCH; Marko ;   et al.
2018-07-19
Bicyclic Tetrahydrothiazepine Derivatives Useful For The Treatment Of Neoplastic And/or Infectious Diseases
App 20180170888 - ERMANN; Monika ;   et al.
2018-06-21
Method For Treating A Gd2 Positive Cancer
App 20180134801 - LOIBNER; Hans ;   et al.
2018-05-17
Treatment Of Inflammatory Illnesses With Ace2
App 20180117126 - LOIBNER; Hans ;   et al.
2018-05-03
Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
Grant 9,839,668 - Poglitsch , et al. December 12, 2
2017-12-12
Preparations and methods for treating a GD2 positive cancer
Grant 9,840,566 - Loibner , et al. December 12, 2
2017-12-12
Method For Measurement Of Peptidic Degradation Products Of A Proteolytic Cascade In Blood Samples
App 20170285048 - Poglitsch; Marko ;   et al.
2017-10-05
Method for treating a GD2 positive cancer
Grant 9,777,068 - Loibner , et al. October 3, 2
2017-10-03
Modified ACE2 polypeptides
Grant 9,757,433 - Loibner , et al. September 12, 2
2017-09-12
Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
Grant 9,684,004 - Poglitsch , et al. June 20, 2
2017-06-20
Treatment of inflammatory illnesses with ACE2
Grant 9,561,263 - Loibner , et al. February 7, 2
2017-02-07
Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System
App 20160310562 - POGLITSCH; Marko ;   et al.
2016-10-27
Preparations and Methods for Treating a GD2 Positive Cancer
App 20160304620 - LOIBNER; Hans ;   et al.
2016-10-20
Combination Of Tumor-associated Surface Protein Antigens And Tumor-associated Sugars In The Treatment And Diagnosis Of Cancer
App 20160000914 - LOIBNER; Hans ;   et al.
2016-01-07
Modified ACE2 polypeptides
App 20150353910 - LOIBNER; Hans ;   et al.
2015-12-10
SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer
Grant 9,186,373 - Lametschwandtner , et al. November 17, 2
2015-11-17
Sirna Against Cbl-b And Optionally Il-2 And Il-12 For Use In The Treatment Of Cancer
App 20150313931 - Lametschwandtner; Gunther ;   et al.
2015-11-05
Method for Tretaing a GD2 Positive Cancer
App 20150139942 - Loibner; Hans ;   et al.
2015-05-21
Method for Measurement of Peptidic Degradation Products of a Proteolytic Cascade in Blood Samples
App 20150050676 - Poglitsch; Marko ;   et al.
2015-02-19
Treatment of tumors
Grant 8,946,162 - Janzek-Hawlat , et al. February 3, 2
2015-02-03
Compositions for Preventing or Treating Adverse Reactions of EGFR Inhibition
App 20140322308 - Loibner; Hans ;   et al.
2014-10-30
Method for increasing immunoreactivity
Grant 8,809,288 - Baier , et al. August 19, 2
2014-08-19
Method for Treating a GD2 Positive Cancer
App 20140170155 - Loibner; Hans ;   et al.
2014-06-19
Ace2 Polypeptide
App 20140099297 - Schuster; Manfred ;   et al.
2014-04-10
Sirna Against Cbl-b And Optionally Il-2 And Il-12 For Use In The Treatment Of Cancer
App 20140010781 - Lametschwandtner; Gunther ;   et al.
2014-01-09
Recombinant ACE2 polypeptide dimer
Grant 8,586,319 - Schuster , et al. November 19, 2
2013-11-19
Use of antibodies for the vaccination against cancer
Grant 8,444,974 - Eckert , et al. May 21, 2
2013-05-21
Method of treating lewis Y-expressing tumors
Grant 8,323,650 - Schuster , et al. December 4, 2
2012-12-04
Method for determining ACE2 activity
Grant 8,241,864 - Loibner , et al. August 14, 2
2012-08-14
Polysaccharide-polypeptide conjugate
Grant 8,153,135 - Loibner , et al. April 10, 2
2012-04-10
Method for Determining the Cbl-b Expression
App 20120040864 - Loibner; Hans ;   et al.
2012-02-16
Use Of Antibodies For The Vaccination Against Cancer
App 20120003232 - ECKERT; Helmut ;   et al.
2012-01-05
Cancer immunotherapy predictive parameters
Grant 8,062,625 - Loibner November 22, 2
2011-11-22
Immunogenic recombinant antibody
Grant 8,034,338 - Loibner , et al. October 11, 2
2011-10-11
Treatment Of Tumors
App 20110033524 - Janzek-hawlat; Evelyne ;   et al.
2011-02-10
Treatment Of Inflammatory Illnesses With Ace2
App 20110020315 - Loibner; Hans ;   et al.
2011-01-27
N-glycosylated Antibody
App 20110020331 - Schuster; Manfred ;   et al.
2011-01-27
Treatment Of Fibroses And Liver Disorders
App 20100316624 - Loibner; Hans ;   et al.
2010-12-16
ACE2 Polypeptide
App 20100310546 - Schuster; Manfred ;   et al.
2010-12-09
Immunogenic, Monoclonal Antibody
App 20100310551 - LOIBNER; Hans ;   et al.
2010-12-09
Method for Determining ACE2 Activity
App 20100261214 - Loibner; Hans ;   et al.
2010-10-14
Method for Increasing Immunoreactivity
App 20100260808 - Baier; Gottfried ;   et al.
2010-10-14
Use Of Antibodies For The Vaccination Against Cancer
App 20100233178 - ECKERT; Helmut ;   et al.
2010-09-16
N-glycosylated antibody
Grant 7,759,464 - Schuster , et al. July 20, 2
2010-07-20
Cancer Immunotherapy Predictive Parameters
App 20100086570 - Loibner; Hans
2010-04-08
Use of antibodies for the vaccination against cancer
Grant 7,691,372 - Eckert , et al. April 6, 2
2010-04-06
General Prognostic Parameters For Tumour Patients
App 20100028932 - Loibner; Hans
2010-02-04
Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant
Grant 7,615,226 - Loibner , et al. November 10, 2
2009-11-10
Use Of A Preparation Based On An Antibody Directed Against A Tumor-associated Glycosylation
App 20090181030 - LOIBNER; Hans ;   et al.
2009-07-16
Combination Of Tumor-associated Surface Protein Antigens And Tumor-associated Sugars In The Treatment And Diagnosis Of Cancer
App 20090130125 - LOIBNER; Hans ;   et al.
2009-05-21
Use of a preparation based on an antibody directed against a tumor-associated glycosylation
Grant 7,527,789 - Loibner , et al. May 5, 2
2009-05-05
N-Glycosylated Antibody
App 20080095783 - Schuster; Manfred ;   et al.
2008-04-24
Immunogenic Recombinant Antibody
App 20070258978 - Loibner; Hans ;   et al.
2007-11-08
Method for Selecting Epitopes for Immunotherapy
App 20070243201 - Loibner; Hans ;   et al.
2007-10-18
Use Of Antibodies For The Vaccination Against Cancer
App 20070224202 - ECKERT; Helmut ;   et al.
2007-09-27
Immunotherapy of rectal cancer
App 20060246056 - Loibner; Hans ;   et al.
2006-11-02
Use of antibodies against tumor-associated antigen
App 20060127403 - Loibner; Hans ;   et al.
2006-06-15
Polysaccharide-polypeptide conjugate
App 20060062796 - Loibner; Hans ;   et al.
2006-03-23
Use of antibodies in a very low dose for the vaccination against cancer
App 20060018901 - Loibner; Hans ;   et al.
2006-01-26
Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer
App 20050255116 - Loibner, Hans ;   et al.
2005-11-17
Polysaccharide-polypeptide conjugate
Grant 6,956,119 - Loibner , et al. October 18, 2
2005-10-18
Use of a preparation based on an antibody directed against a tumor-associated glycosylation
App 20050226880 - Loibner, Hans ;   et al.
2005-10-13
Immunogenic monoclonal antibody
App 20050181475 - Loibner, Hans ;   et al.
2005-08-18
Use of a vaccine for active immunization against cancer
App 20050169929 - Himmler, Gottfried ;   et al.
2005-08-04
Monoclonal antibodies and their use
App 20050163768 - Eckert, Helmut ;   et al.
2005-07-28
Use of antibodies for the vaccination against cancer
App 20040265318 - Eckert, Helmut ;   et al.
2004-12-30
Method for producing a vaccine
App 20040191242 - Himmler, Gottried ;   et al.
2004-09-30
Use of polyclonal immunoglobulins
App 20040151717 - Loibner, Hans ;   et al.
2004-08-05
Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant
App 20030143221 - Loibner, Hans ;   et al.
2003-07-31
Polysaccharide-polypeptide conjugate
App 20030120033 - Loibner, Hans ;   et al.
2003-06-26
Monoclonal antibodies and their use
App 20020146410 - Eckert, Helmut ;   et al.
2002-10-10
Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
Grant 5,562,903 - Co , et al. October 8, 1
1996-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed